Impact of homocysteine on cortical perfusion and cognitive decline in mild Alzheimer's dementia

European Journal of Neurology

Volumn 20, Issue 8, 2013, Pages 1191-1197

  Huang, C W ^a,b   Chang, W N ^a   Huang, S H ^a   Lui, C C ^a   Chen, N C ^a   Chang, Y T ^a   Lee, C C ^a   Chang, C C ^a,b   Chang, A Y W ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; Cortical perfusion; Homocysteine; Longitudinal decline; Single photon emission computed tomography

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; NEUROTOXICITY; PRIORITY JOURNAL; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ALZHEIMER'S DISEASE; CORTICAL PERFUSION; HOMOCYSTEINE; LONGITUDINAL DECLINE; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PERFUSION; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84880135469     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12159     Document Type: Article

References (32)

1. McCaddon A, Davies G, Hudson P, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998; 13: 235-239.
2. Seshadri S. Homocysteine and the risk of dementia. Clin Chem 2012; 58: 1059-1060.
3. Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 2002; 59: 787-793.
4. Huang CW, Chang WN, Lui CC, et al. Impacts of hyper-homocysteinemia and white matter hyper-intensity in Alzheimer's disease patients with normal creatinine: an MRI-based study with longitudinal follow-up. Curr Alzheimer Res 2010; 7: 527-533.
5. Vermeer SE, van Dijk EJ, Koudstaal PJ, et al. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol 2002; 51: 285-289.
6. Seshadri S, Wolf PA, Beiser AS, et al. Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyper-intensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol 2008; 65: 642-649.
7. Oulhaj A, Refsum H, Beaumont H, et al. Homocysteine as a predictor of cognitive decline in Alzheimer's disease. Int J Geriatr Psychiatry 2010; 25: 82-90.
8. Tu MC, Huang CW, Chen NC, et al. Hyper-homocysteinemia in Alzheimer dementia patients and cognitive decline after 6 months follow-up period. Acta Neurol Taiwan 2010; 19: 168-177.
9. Masdeu JC, Arbizu J. Brain single photon emission computed tomography: technological aspects and clinical applications. Semin Neurol 2008; 28: 423-434.
10. Scheid R, Preul C, Lincke T, et al. Correlation of cognitive status, MRI- and SPECT-imaging in CADASIL patients. Eur J Neurol 2006; 13: 363-370.
11. O'Brien JT. Role of imaging techniques in the diagnosis of dementia. Br J Radiol 2007; 80(Spec No 2): S71-S77.
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
13. Rockwood K, Strang D, MacKnight C, Downer R, Morris JC. Inter-rater reliability of the Clinical Dementia Rating in a multi-center trial. J Am Geriatr Soc. 2000; 48: 558-559.
14. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980; 7: 486-488.
15. Gavin JR 3rd. New classification and diagnostic criteria for diabetes mellitus. Clin Cornerstone 1998; 1: 1-12.
16. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc 2003; 289: 2560-2572.
17. Chang CC, Liu JS, Chang YY, Chang WN, Chen SS, Lee CH. (99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: a correlation with neuropsychological tests. Eur J Neurol 2008; 15: 61-65.
18. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labelling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15: 273-289.
19. Pickut BA, Dierckx RA, Dobbeleir A, et al. Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type. Psychiatry Res 1999; 90: 103-112.
20. Reed BR, Eberling JL, Mungas D, Weiner M, Kramer JH, Jagust WJ. Effects of white matter lesions and lacunes on cortical function. Arch Neurol 2004; 61: 1545-1550.
21. Sachdev P. Homocysteine, cerebrovascular disease and brain atrophy. J Neurol Sci 2004; 226: 25-29.
22. Poddar R, Paul S. Homocysteine-NMDA receptor-mediated activation of extracellular signal-regulated kinase leads to neuronal cell death. J Neurochem 2009; 110: 1095-1106.
23. Bronge L, Wahlund LO. White matter changes in dementia: does radiology matter? Br J Radiol 2007; 80(Spec No 2): S115-S120.
24. Emanuele E, Martinelli V, Abbiati V, Ricevuti G. Linking atherosclerosis to Alzheimer's disease: focus on biomarkers. Front Biosci (Elite Ed) 2012; 4: 700-710.
25. Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol 2012; 11: 1006-1012.
26. Johnson KA, Albert MS. Perfusion abnormalities in prodromal AD. Neurobiol Aging 2000; 21: 289-292.
27. McCaddon A, Hudson P, Davies G, Hughes A, Williams JH, Wilkinson C. Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001; 12: 309-313.
28. Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A 3rd. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 2005; 82: 627-635.
29. Dufouil C, Alperovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyper-intensities, and cognition in healthy elderly people. Ann Neurol 2003; 53: 214-221.
30. Garcia A, Haron Y, Pulman K, Hua L, Freedman M. Increases in homocysteine are related to worsening of Stroop scores in healthy elderly persons: a prospective follow-up study. J Gerontol A Biol Sci Med Sci 2004; 59: 1323-1327.
31. Goyette P, Christensen B, Rosenblatt DS, Rozen R. Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR. Am J Hum Genet 1996; 59: 1268-1275.
32. Bottiglieri T. Folate, vitamin B12, and neuropsychiatric disorders. Nutr Rev 1996; 54: 382-390.